Adipogen/Lysolipin I/BVT-0037-M001/1 mg
商品编号：
BVT-0037-M001
品牌：
Adipogen Inc
市场价：
¥3400.00
美元价：
2040.00
产品分类：
其他试剂
公司分类：
Other_reagents
联系Q Q：
3392242852
电话号码：
4000-520-616
电子邮箱：
info@ebiomall.com
商品介绍
| Product Details | |
|---|---|
| Product Type | Chemical |
| Properties | |
| Formula | C29H24ClNO11 |
| MW | 597.9 |
| CAS | 59113-57-4 |
| Source/Host Chemicals | Isolated from Streptomyces violaceoniger. |
| Purity Chemicals | ≥98% (HPLC) |
| Appearance | Yellow needles. |
| Solubility | Soluble in methylene chloride, DMSO or chloroform. |
| Identity | Determined by 1H-NMR. |
| Declaration | Manufactured by BioViotica. |
| InChi Key | NEOMIZJYHXSRLV-GLWRQVQYSA-N |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice | Protect from light. |
| Use/Stability |
Stable for at least 1 year after receipt when stored at -20°C. After reconstitution protect from light at -20°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
- Antibiotic.
- Glycopeptide synthesis inhibitor.
- Antibacterial, antifungal and anticoccidial.
- Cytotoxic.
Product References
- Lysolipin I, ein neuer Hemmstoff der bakteriellen Zellwandsynthese.: H. Drautz, et al.; Path. Microbiol. 42, 236 (1975)
- Metabolic products of microorganisms, 149. Lysolipin I, a new antibiotic from streptomyces violaceoniger: H. Drautz, et al.; Arch. Microbiol. 106, 175 (1975)
- Structure of cervinomycin, a novel xantone antibiotic active against anaerobe and mycoplasma.: A. Nakagawa, et al.; J Antibiot 40, 301 (1987)
- Biosynthetic studies on the xanthone antibiotics lysolipins X and I: H. Bockholt, et al.; J. Org. Chem. 59, 2064 (1994)
- Experiments on the total synthesis of Lysolipin I. Part II. Michael addition of 1,3-cyclohexanedione to quinone acetals: R.O. Duthaler & U.H.U. Wegmann; Helv. Chim. Acta 67, 1755 (2004)
- Isolation of the lysolipin gene cluster of streptomyces Tandae Tu 4042: P. Lopez, et al.; Gene 461, 5 (2010)
品牌介绍
Adipogen公司由三个子公司组成，分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国，运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发，如癌症、免疫、炎症、代谢疾病（糖尿病、肥胖）、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外，也可提供抗体和蛋白产品，Adipogen拥有自己的化学实验室，致力于开发创新型小分子化合物。
联络我们
